[Skip to Navigation]
Comment & Response
May 2017

Cetuximab and Radiotherapy in Laryngeal Preservation

Author Affiliations
  • 1Department of Otolaryngology–Head & Neck Surgery, Carlo Poma Civil Hospital, Mantova, Italy
  • 2 Section of Otolaryngology–Head & Neck Surgery, Department of Surgical and Biomedical Sciences, University of Perugia, Italy
JAMA Otolaryngol Head Neck Surg. 2017;143(5):525-526. doi:10.1001/jamaoto.2016.3821

To the Editor We read with interest the article “Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial” by Bonner et al.1 We congratulate the authors on their phase 3 clinical trial, however, some potentially misleading ambiguities can be noticed in their article.

Add or change institution